Thus, pretreatment with a single low loading dose of TXL 1 hour before ischemia reduces the myocardial no-reflow phenomenon and ischemia-reperfusion injury by upregulating the phosphorylation of eNOS at Ser1179 and Ser635, and this effect is partially mediated by the PKA pathway [64]. Here, TXNL1 is linked to ischemia.